Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
228 articles
A major Cochrane network meta-analysis protocol will rank all insulin regimens by efficacy and safety for adults with type 1 diabetes.
A comprehensive review finds SGLT2 inhibitors reduce AKI risk in humans via hemodynamic, metabolic, and cellular protective pathways.
Expert reviews of top CGM platforms reveal genuine metabolic insights — but no proof they extend lifespan in healthy adults.
Wearable microneedle patches tap interstitial fluid to monitor glucose, lactate, and electrolytes in real time — no needles, no lab.
Go deeper into how AMPK detects energy stress, activates upstream kinases, and coordinates metabolism, autophagy, and longevity pathways at the molecular level.
Foundayo (orforglipron) becomes the first oral GLP-1 receptor agonist approved for obesity, offering a pill alternative to injectable Wegovy.
A novel conjugate merges GLP-1/GIP incretin signaling with pan-PPAR activation in one molecule, potentially revolutionizing metabolic therapy.
Discover AMPK — the master switch inside your cells that monitors energy levels and triggers powerful anti-aging responses when activated.
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims — most fall short of the hype.
Early bile acid and incretin responses after duodeno-ileal diversion may forecast long-term glycaemic outcomes in metabolic disease.
Men with T2D showed significantly greater postural instability after exercising in humid heat, despite normal thermoregulatory responses.
Combining cold exposure with exercise activates a key metabolic pathway to reduce liver fat and fibrosis more effectively than either intervention alone.
